Moreover, BCL-2, the inhibitor of apoptosis, was restrained in the kidney of T2DM rats, and HSYA could upregulate BCL-2 in a certain extent (Figure 5(d) and 5(e)) (vs. Mod P < 0.05). This evidence concerns the gene BCL2 and type 2 diabetes mellitus.